SULFAMIDO- AND SULFAMIDO-CARBONYLPYRIDINE-2-CARBOXYLIC ACID AMIDES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION Russian patent published in 1999 - IPC

Abstract RU 2129545 C1

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to sulfamido- and sulfamido-carbonylpyridine- -2-carboxylic acid amides of the formula (I) where A is R3 and B is -X-NR6R7; or B is R3 and A is -X-NR6R7; X - a simple bond or -CO-; R1,R2,R3 are similar or distinct and mean hydrogen atom, unsubstituted C1-C4-alkyl, (C1-C6)-alkoxy-group, fluorine, bromine atoms; R4,R5 - H independently each of other, C1-C8-alkyl, C6-C10-aryl, C7-C11-ar-C1-C6-alkyl, C1-C8-alkyloxy-group possibly once substituted with hydroxy-, carboxy-, C1-C6-alkyloxycarbonyl, C1-C6-alkoxy-group; R6 - H, C1-C6-alkyl, monovalent physiologically acceptable cation - Na+,K+; R7 - residue of the formula (II) (for exception SO2H), Y-[C-V]r-D-W where Y is SO2; C - a bond, C1-C8-aliphatic alkanediyl; V - bond, -O-; D - bond; W is H, thienyl, C6-C10-aryl being V means -O- if C does not mean a bond and W is substituted preferably with, for example, a group -O-(CH2)xCfH(2f+1-q)Fq; f = 1-8; q = 0.1-(2f + 1); z = 1, 2; X = 0-8. Synthesized compounds are used in a pharmaceutical composition showing an antifibrous activity. Compound where X - a simple bond is synthesized from aminopyridine-2-carboxylate and derivative of sulfonic acid followed by interaction of obtained compound with amine. Compound (I) where X means -CO- is synthesized from pyridine-2-carboxylic acid carboxylate ester. EFFECT: improved method of synthesis, antifibrous activity of compounds synthesized. 7 cl, 1 tbl, 2 dwg

Similar patents RU2129545C1

Title Year Author Number
ESTERS OF ACYLSULFONAMIDO- AND SULFONAMIDOPYRIDINE-2-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND A METHOD OF ITS PREPARING 1993
  • Klaus Vajdmann
  • Martin Bikel'
  • Fol'Kmar Gjuntsler-Pukall
  • Karl-Khajnts Baringkhauz
RU2117660C1
HETEROCYCLIC DERIVATIVES OF CARBOXYLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1994
  • Klaus Vejdmann
  • Karl-Gejnts Baringkhauz
  • Georg Tshank
  • Martin Bikel'
RU2145959C1
METHOD OF PREPARING N-ACYL-ALFA-AMINO ACIDS 1995
  • Matkhias Beller
  • Khartmut Fisher
  • Tomas Gerdau
  • Peter Gros
RU2140903C1
AGENT FOR PROTECTION OF CULTURED PLANTS FROM PHYTOTOXIC ADVERSE EFFECT OF HERBICIDES, N- ACYLSULFONAMIDES 1997
  • Tsimer Frank
  • Khaaf Klaus
  • Vill'Ms Lotar
  • Bauer Klaus
  • Biringer Khermann
  • Rozinger Kristofer
RU2182423C2
IMIDAZO-ANNELATED ISO- AND HETEROCYCLES AND METHOD FOR THEIR PRODUCTION 1992
  • Khol'Ger Khajch[De]
  • Adal'Bert Vagner[De]
  • Khajnts-Verner Kleemann[De]
  • Khermann Gerkhards[De]
  • Bernvard Shel'Kens[De]
RU2076105C1
METHOD OF SYNTHESIS OF AMINOPHENYLSULFONYLUREAS (VARIANTS), INTERMEDIATE COMPOUNDS 1996
  • Shnabel' Gerkhard
  • Fermeren Jan
  • Vill'Ms Lotar
RU2177003C2
NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR 1997
  • Fol'Kmar Vener
  • Jokhen Knolle
  • Khans Ul'Rikh Shtilts
  • Zhan-Fransua Gurve
  • Deni Karniato
  • Tomas Richard Gadek
  • Robert Makdauehll
  • Robert Moris Pitti
  • Sara Kehtrin Boudari
RU2180331C2
FIVE-MEMBERED HETEROCYCLES AS INHIBITORS OF LEUKOCYTE ADHESION AND VLA-4 ANTAGONISTS 1997
  • Shtil'Ts Khans Ul'Rikh
  • Vener Fol'Kmar
  • Knolle Jokhen
  • Bartnik Ehkart
  • Khjul'S Kristof
RU2229296C2
IMIDAZOLE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, AGENT FOR BLOOD HYPERTENSION DECREASE AND PHARMACEUTICAL COMPOSITION FOR BLOOD PRESSURE DECREASE 1993
  • Kholger Khajch
  • Rainer Khenning
  • Adal'Bert Vagner
  • Khermann Gerkhards
  • Rajnkhard Beker
  • Bernvard Shel'Kens
RU2116300C1
NOVEL TETRAZOLONE DERIVATIVES 2014
  • Greter Uve
  • Nettekofen Mattias
  • Pyullmann Bernd
  • Refer Shtefan
  • Rodzhers-Evans Mark
  • Shults-Gash Tanya
RU2664644C2

RU 2 129 545 C1

Authors

Klaus Vajdmann

Martin Bikel'

Fol'Kmar Gjuntsler-Pukall

Dates

1999-04-27Published

1993-03-23Filed